ICHRAs are gaining a lot of interest in healthcare. Some say they are beneficial because they give employees more choice in their health insurance, while others are more skeptical.
Novo Nordisk's amycretin is a single molecule designed to bind to two targets to spark weight loss — a different approach than some of the pharma giant's other efforts to develop next-generation obesity drugs. Analysts say the lack of safety and tolerability details make it difficult to fully assess the preliminary Phase 1b/2a results.
January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For example, health tech companies like Medtronic and athenahealth hired new C-suite leaders, and providers like Cleveland Clinic and Jefferson Health announced rounds of job cuts.
Joseph DeVivo, CEO of portable ultrasound device firm Butterfly Network, led the company's return to revenue growth in 2024. Now, he wants to have the device be firmly entrenched in hospitals.
We now have the ability to diagnose and treat with data-driven insights and deliver measurable outcomes. It's on us as providers to ensure that we are consistently adopting the latest, proven technology and treatment modalities that can benefit our patients.
The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.
Post Comment
No comments